Efficacy and safety of oral semaglutide monotherapy vs placebo in a predominantly Chinese population with type 2 diabetes (PIONEER 11): a double-blind, Phase IIIa, randomised trial.

ABSTRACT:

SUBMITTER: Wang W 

PROVIDER: S-EPMC11410837 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature